The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. The top-performing stocks tend to have a 95 or better grade as they ...

Synopsys, Inc. (SNPS) is currently at $646.13, up $53.50 or 9.03% --Would be new all-time high (Based on available data back to Feb. 26, 1992) --Would be the first new record closing high since July 5 ...

Cadence Design Systems (CDNS) tops Q2 expectations, lifts 2025 outlook amid AI-driven demand. Analysts boost price targets; ...

Dental caries remains a significant global public health burden, affecting billions worldwide despite preventive measures. While behavioral and ...

There's plenty of reason to be optimistic about Synopsys' future; however, whether it could realistically make you a ...

The workshop is open to early-career and seasoned journalists who are passionate about improving the quality of reporting ...

Researchers evaluated the relative importance of phenotypic and genetic factors in predicting risk for head and neck cancer.

Shares of Synopsys Inc. SNPS slid 1.33% to $601.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.40% to 6,388.64 and ...

This study reveals how machine learning models uncover new genetic variants linked to Alzheimer’s, advancing predictive ...

Buying $1000 In SNPS: If an investor had bought $1000 of SNPS stock 15 years ago, it would be worth $26,611.09 today based on a price of $587.59 for SNPS at the time of writing.

A team of researchers has developed the first high-resolution genetic map and a versatile SNP chip for Panax ginseng, a ...